PRESENTATION

H1 FY2021 — Results presentation

H1 FY2021PDF · 85 pages16.2 MB
1
1
for the six months ended 31 December 2020

-- 1 of 85 --

2
+8% including DH take-on of new closed
schemes and gross revenue for Vitality Group
Core new business API
to R9 916m
Normalised operating
profit
to R4 507m
Normalised headline
earnings
to R2 284m
COVID-19 provisions Headline earnings
to R1 842m	unchanged
SA COMPOSITE MODEL UK COMPOSITE MODEL PARTNER
COMPOSITE MODEL
Health	
Life	
Invest
Robust operating performance with prudent COVID-19 provision
Operating model performing well and driving growth, with strength in capital and liquidity
A pivot to growth following trends emerging through COVID-19
The businesses well positioned in the four strategic strands

-- 2 of 85 --

3
Claims paid*
New cases
-
2,000
4,000
6,000
8,000
10,000
12,000
14,000
16,000
18,000
20,000
07-Jul-19	
18-Aug-19	
29-Sep-19	
10-Nov-19	
22-Dec-19	
02-Feb-20	
15-Mar-20	
26-Apr-20	
07-Jun-20	
19-Jul-20	
30-Aug-20	
11-Oct-20	
22-Nov-20	
03-Jan-21	
14-Feb-21
-
10,000
20,000
30,000
40,000
50,000
60,000
70,000
07-Jul-19	
18-Aug-19	
29-Sep-19	
10-Nov-19	
22-Dec-19	
02-Feb-20	
15-Mar-20	
26-Apr-20	
07-Jun-20	
19-Jul-20	
30-Aug-20	
11-Oct-20	
22-Nov-20	
03-Jan-21	
14-Feb-21
New cases
Discovery data to date
Tests
conducted
Confirmed
positive cases
Members
admitted
*DH: All COVID care on the DHMS scheme for COVID-19 positive members, DL: Individual and Group Risk gross claims, VL: gross claims, VH: Health COVID-19 cash benefit
Staff deaths
Deaths across
DH, DL and VL

-- 3 of 85 --

4
Our strategic response to the pandemic
Keep every staff member safe
Maintain connectivity
Live out our values
Ensure business continuity
Ensure products are fit-for-purpose
Keep people healthy and active
Ensure operating profit strong with appropriate and conservative reserve for COVID-19
Minimise the impact on liquidity and solvency
Protect the capital plan
Maintain financial strength and resilience
Support the healthcare system
Strengthen the healthcare system
Play an outsized role
COVID Alert
SA app
DISCOVERY
talks
COVID-19
information
hub
Support
our country
Protect
our people
Protect and
support our clients
Vitality
at Home
COVID-19
concessions
till Dec 20
Wellbeing
at Home Oximeter
benefit
COVID-19
Business
Support
GP initiated
virtual
consults
SA vaccine
programme
support
Connected
Care

-- 4 of 85 --

5
UK’s second wave was a lot more severe on a national level than for
VitalityLife, but tapering off
Second wave tapering off VitalityLife had higher mortality in
the first wave, in FY20
COVID-19 variant more severe
Deaths	Infections
New deaths per day
New infections per day
UK distribution of strains
-
10,000
20,000
30,000
40,000
50,000
60,000
70,000
05-Jan-20	
02-Feb-20	
01-Mar-20	
29-Mar-20	
26-Apr-20	
24-May-20	
21-Jun-20	
19-Jul-20	
16-Aug-20	
13-Sep-20	
11-Oct-20	
08-Nov-20	
06-Dec-20	
03-Jan-21	
31-Jan-21
 -
200
400
600
800
1,000
1,200
1,400
19A
20A
20D
20B
20E
20I/501Y.V1
Mar	Jan 20 Jul	May Nov	Sep Jan 21
COVID-19 infections and deaths
More patients in
hospital
More
deaths
National wave 2 vs wave 1:
0
1
2
3
4
VL COVID-19 related deaths
FY 20
Deaths:
H1 21 H2 21

-- 5 of 85 --

6
SA’s second wave also more severe but rapidly decreasing
Higher morbidity
Admission rates
Fewer out-of-hospital claims
Acute medication utilisation
Shorter average length of stay
OH admissions discharged with oxygen
Higher exposure
Discovery Life claims paid* (Rm)
0
100
200
300
400
500
600
-
5,000
10,000
15,000
20,000
25,000
Average deaths per day
Average new infections per day
Daily new infections Avg daily new infections Avg daily new deaths
1.5x
peak wave 1
South Africa daily new infection trends
SA’s second wave more serious than first, and started in
holiday season
Comparison between waves using Discovery data
Higher socio-economic classes hit harder
Deaths DL and DH
*Individual and Group Risk gross claims

-- 6 of 85 --

7
Behaviour and a new variant contributed to a second wave
-100
-80
-60
-40
-20
0
20
40
Google mobility trends report
https://www.google.com/covid19/mobility/
Positive tests per million South Africa distribution of strains,
superimposed infection and death rates
-
200
400
600
800
1,000
1,200
1,400
20201101	
20201106	
20201111	
20201116	
20201121	
20201126	
20201201	
20201206	
20201211	
20201216	
20201221	
20201226	
20201231	
20210105	
20210110	
20210115	
20210120	
20210125	
20210130	
20210204	
20210209
16-20 age band Rest of membership
higher risk of
infection compared
to those who didn’t
have a flight
Dec
Mobility increased early December
as SA entered holiday season
COVID-19 variant 40-50% more
transmissible
Spike in young infections post-matric
celebratory events and spread to other
members
Mar	Jan 20 Jul	May Nov	Sep Jan 21
20D
20B
20A
0
5
10
0
5
10
15
20
25
30
35
New deaths per million per day
New infections per 100,000 per day	
20H/501Y.V2
Deaths	Infections

-- 7 of 85 --

8
Understanding immunity
0.28% 0.33% 0.39%
85% 70% 59% 51%
90% 74% 62% 54%
95% 78% 66% 57%
IFR
Excess deaths
directly
attributable
to COVID-19
Expect majority of excess deaths to be due to COVID-19
RSA (natural) excess deaths and reported confirmed COVID-19 deaths
Expect 51-57% population infected
20 000
15 000
10 000
5 000
0
-5 000
1 Jan 20	
1 Apr 20
1 Jul 20
1 Oct 20	
1 Jan 21
Week beginning
Excess deaths Reported confirmed COVID-19 deaths
https://www.samrc.ac.za/reports/report-weekly-deaths-south-africa
Deaths = [ Population infected ] x [ Infection Fatality Rate ]
Consistent with SANBS study on the prevalence of
COVID antibodies – c52% donors tested positive
∴ Population infected = [ Deaths / Infection Fatality Rate ]

-- 8 of 85 --

9
The blood samples from half the
people we tested showed that all
neutralising activity was lost. This
suggests that they may no longer
be protected from reinfection
Understanding reinfection rates
Discovery Health data suggests very low
reinfection risk, even with second variant
Reinfections = [ Confirmed positives in wave 1 ] x
[ Reinfection rate for those who have recovered ] x
[ Probability of testing positive in the second wave ] Confirmed positives
in wave 1, recovered more than
90 days prior to wave 2
Vulnerable to reinfection
in wave 2 (assume one third)
Risk of positive test in wave 2 in
DSY Health 2.7%
Actual reinfections
Source: The evolving science behind long COVID
https://mg.co.za/news/2021-01-19-can-you-get-reinfected-with-covid-19-sa-has-4-000-potential-reinfections/
https://www.washingtonpost.com/health/2021/02/05/virus-variant-reinfection-south-africa/
Neutralising antibodies are
about a third less by 6 months
after hospitalisation
Professor Clive Gray
Concerns about reinfection rates
National Health
Laboratory Service
In the placebo group of the trial for Novavax’s vaccine, people with prior
coronavirus infections appeared just as likely to get sick as people without
them, meaning they weren’t fully protected against the B.1.351 variant that
has swiftly become dominant in South Africa
Washington Post
Discovery Health data suggest 28% are
vulnerable to reinfection

-- 9 of 85 --

10
Factors that influence COVID-19 waves
(1-Immunity) x P(contact) x Risk index	COVID Wave =
Herd immunity
Reinfection rates
Vaccines
Behaviour
COVID-19 variants
Community
prevalence
Resilience index

-- 10 of 85 --

11
Incremental deaths under the medium scenario
Scenarios assume IFR = 0.39% and 1/3 reinfection
-
200
400
600
800
1,000
1,200
1,400
1,600
1,800
2,000
20200201	
20200221	
20200312	
20200401	
20200421	
20200511	
20200531	
20200620	
20200710	
20200730	
20200819	
20200908	
20200928	
20201018	
20201107	
20201127	
20201217	
20210106	
20210126	
20210215	
20210307	
20210327	
20210416	
20210506	
20210526	
20210615	
20210705	
20210725	
20210814	
20210903	
20210923	
20211013	
20211102	
20211122	
20211212
The likelihood of a third wave
Projected deaths vs
second wave deaths
Feb-Jun
0x
0.6x
0.2x
Second wave
run-off
Super spreader at
Easter, with
reinfections
Super spreader at
Easter, with
reinfections, but
with vaccine rollout
Jul-Dec
0.2x
0.4x
0.3x
Total
expected
deaths
16.6k
92.5k
44.4k

-- 11 of 85 --

Robust operating
performance with prudent
COVID-19 provision
1

-- 12 of 85 --

13
1 670 +6% 3 167 -5%
1 922 +3% 1 162 -6%
471 -3% 1 316 -3%
107 +43% 617 +12%
SA Composite2 4 170 +5% 6 262 -4%
613 +24% 638 +4%
327 +206% 561 -13%
UK Composite2 940 +56% 1 199 -5%
238 +116% 625 +21%
112 +65% 1 805 +31%
New businesses (999) +0% 1 005 +169%
Rm
SA Composite
UK Composite
Partner
Composite
Excludes SA Vitality
1 Including new closed schemes
2 Excluding New initiatives
Operating profit
R4.5bn
New business
R10.9bn
Health insurance
Life insurance
Continued operational excellence with significant support to
members and society
Excellent operating performance and positive variances delivering
growth on an optimised capital base
High-quality earnings driven by positive flows and market growth
albeit in difficult market conditions
Strong new business and retention dynamics driving growth
with consistently expanding margins and proven efficacy of the
model
Excellent performance driven by continued retention and proven
relevance of the model
Robust recovery with positive lapse experience and resilience to
interest rate volatility
Global relevance gaining significant traction with excellent
operating performance and considerable effect on our partners
Continuation of remarkable revenue, new business and profit
growth
Prudent Bank rollout pivoting towards growth, with other segments
gaining further traction
1

-- 13 of 85 --

14
30-Jun-20 Claims and lapse
unwind
Net new and new
business COVID-19
provisions*
31-Dec-20 30-Jun-20 Net movement
in claims and
lapses
New business
COVID-19
provision
Additional
claims provision
31-Dec-20
COVID-19 provisions back to R3.4bn in December 2020
*GBP11.7m released from COVID provision used to strengthen long-term lapse assumptions
and net movements in UPR
Health insurance	Life insurance
£69.8m
£64.9m
R2 160m
R1 953m
1 023
lapses
956
claims
Invest
Invest
DL claims reserve at the end of January can cover a 3rd wave
~ equal to the 1st wave, plus the lapse provision

-- 14 of 85 --

15
Currency and interest rates volatile over the period
Rapid strengthening of the rand Sustained elevated long-term interest rates in SA
in USD average
vs Dec 19
12
14
16
18
20
22
24
26
Dec-31	
Jan 16	
Feb 01	
Feb 17	
Mar 04	
Mar 20	
Apr 05	
Apr 21	
May 07	
May 23	
Jun 08	
Jun 24	
Jul 10	
Jul 26
Aug 11	
Aug 27	
Sep 12	
Sep 28	
Oct 14	
Oct 30	
Nov 15	
Dec 01	
Dec 17
GBP/ZAR USD/ZAR
in GBP average
vs Dec 19
Average Dec 20 Average Jun 20 Average Dec 19
vs Jun 20
closing GBP
vs Jun 20
closing USD
Spot vs Average real rates: 20-year point
0%
1%
2%
3%
4%
5%
6%
Jan-15
May-15	
Sep-15	
Jan-16
May-16	
Sep-16	
Jan-17
May-17	
Sep-17	
Jan-18
May-18	
Sep-18	
Jan-19
May-19	
Sep-19	
Jan-20
May-20	
Sep-20	
Jan-21
May-21
PIT Spot Rates Avg Spot Rates	Spot rate Average rate

-- 15 of 85 --

16
Reported profit for period affected by currency and interest rates
Rm
6 months
ended
Dec 2020
6 months
ended
Dec 2019
%
Normalised profit from operations before economic
assumptions adjustments 4,507 3,792 19%
Economic assumptions adjustment DL* (493) -
Economic assumptions adjustment VL* 1 (230)
Normalised profit from operations after economic
assumptions adjustments 4,015 3,562 13%
Finance charges excl. 1DP finance lease -649 -581
Forex and remeasurement of currency derivatives -569 33
Deferral fees related to Prudential Book transfer -96 0
Investment income and fair value remeasurements 149 196
Other -231 -235
Profit before tax 2,619 2,975 -12%
Tax (744) (897)
Profit attributable to preference shareholders (34) (41)
Profit attributable to equity holders 1,841 2,037 -10%
Other 1 10
Headline earnings 1,842 2,047 -10%
Economic assumptions adjustment (DL and VL)* 354 186
Remeasurement of currency derivatives 149 8
Other -61 71
Normalised headline earnings 2,284 2,312 -1%
*Net of discretionary margins and net of gains/(losses) on derivatives to offset such changes in economic assumptions
+19% -10% -1%
Recon Dec 20 vs Dec 19 growth
Normalised
operating
profit
Finance
charges
Forex and
currency
Economic
assumptions
(normalised)
Tax and other Headline
earnings
Normalisation
adjustment
Normalised
headline
earnings
+1%
-19%
-9% -3%
+9%
derivatives
remeasurements
Currency Interest
rates
Interest
rates

-- 16 of 85 --

Operating model performing well
and driving growth, with strength in
capital and liquidity
2

-- 17 of 85 --

18
Group operating model
Cash
generated
Cash
used
Tax
New
business
Funding
Cash
spent
Finance
costs and
dividends
New
businesses
<50%
per
business
Operating cashflow Net cashflow
Growth Engine Cash Management
Capital Model
SA Liquidity
R1-2bn
FLR
< 28%
Capital
Regulatory
capital and
reserves
Allocated
capital for
planned
initiatives
Allocated
debt
Allocated debt is
part of the
funding strategy
Additional
buffer
Buffer for volatility
and unknown
investments
1 in 25	
year event
~5 years
~5 years
ESTABLISHED
EMERGING
NEW
Normalised
Operating
Profit
ROC
RF + 10%
Group profit growth

-- 18 of 85 --

19
Strong growth from Emerging and slowing
investment in New
1 670 +6%
1 922 +3%
471 -3%
613 +24%
327 +206%
Established 5 003 +10%
107 +43%
238 +116%
112 +65%
Emerging 457 +81%
New (999) +0%
Rm
Operating profit
R4.5bn
Health insurance
Life insurance	
ESTABLISHED BUSINESSES
EMERGING BUSINESS
NEW
Established excludes SA Vitality, including SA Vitality Established is R5 049m
-250
0
250
500
H1 2017 H1 2018 H1 2019 H1 2020 H1 2021
0
400
800
1,200
H1 2017 H1 2018 H1 2019 H1 2020 H1 2021
+81%
+50%
+71%
-0%	+81%
+113%
+65%

-- 19 of 85 --

20
3 167 -5%
1 162 -6%
1 316 -3%
638 +4%
561 -13%
Established 6 844 -5%
617 +12%
625 +21%
1 805 +31%
Emerging 3 047 +24%
New 1 005 +169%
Rm
New business
R10.9bn
Health insurance
Life insurance	
ESTABLISHED BUSINESSES
EMERGING BUSINESS
NEW
-
1,000
2,000
3,000
4,000
H1 2017 H1 2018 H1 2019 H1 2020 H1 2021
32%
5 yr CAGR
171%
2 yr CAGR
-
400
800
1,200
H1 2017 H1 2018 H1 2019 H1 2020 H1 2021
1
Established excludes SA Vitality, including SA Vitality Established is R6 868m
1 Including new closed schemes
+24%
+20%
+55%
+30%
+169%
+173%
Emerging and New contributed to strong
total new business API

-- 20 of 85 --

21
Despite small earnings contribution from Emerging and New, they
contribute significantly to revenue and membership growth
-
2,000
4,000
6,000
8,000
10,000
12,000
H1
2017
H1
2018
H1
2019
H1
2020
H1
2021
Total new business API	“Revenue”
“Revenue” share
"Gross inflows + Bank revenue + 25% PAH GWP"
Total new business
API share
63%
28%
9%
84%
16%
87%
13%
73%
26%
1%
H1 2018
H1 2021
-
5,000
10,000
15,000
20,000
25,000
30,000
35,000
40,000
45,000
H1
2018
H1
2019
H1
2020
H1
2021

-- 21 of 85 --

22
Emerging businesses are scaling and creating value
H1
2017
H1
2018
H1
2019
H1
2020
H1
2021 H1
2017
H1
2018
H1
2019
H1
2020
H1
2021
H1
2017
H1
2018
H1
2019
H1
2020
H1
2021
Operating profit Operating profit Operating profit
ROE ROE ROE
-114
99
169
253
457
H1 2017 H1 2018 H1 2019 H1 2020 H1 2021
Strong growth from Emerging
13.5%ROE
Operating profit
Rm
ROEs for the six months to December 2020, annualised

-- 22 of 85 --

23
New market
launches over
next 18 months
New businesses continue to see considerable traction
VitalityInvest DBI	Umbrella Funds
+77%
to R124m
+247%
to R592m
R6.1bn
J A S O N D J F M A M J J A S O N D J
Retail deposits
GBP millions
+95%
to £151.2m
New business New business
J S N J M M J S N J M M J S N J A O D F A J A O D F A J A O D
New business APE
J S N J M M J S N J M M J S N
Bank Vitality1
2020 2021	2019 2019 2020	2018 2019 2020	2018 2019 2020	2018
5% 7%
15%
26% 22%
H1
2017
H1
2018
H1
2019
H1
2020
H1
2021
% in New decreasing
Cumulative new business Cumulative new business Cumulative new business
BRAZIL
MEXICO	ISRAEL
CZECH
REPUBLIC
SPAIN ITALY
POLAND
VIETNAM
61%	15%
8%
16%
Bank VG VI Other
Majority in Bank
53%
9%
16%
22%
H1
2020
H1
2021
+123%
ZAR

-- 23 of 85 --

24
Cash
generated
Cash
used	Funding
New business
Net cash flow1
New businesses
Net cash
generated from
in-force business
R5.8bn
Tax and finance
costs
R1.5bn
R3.9bn
R0.4bn
R0.9bn
Cash management supports the growth methodology
Cash generated from in-force
1 Movement in shareholder free cash
Cash used net of funding
Net cash flow
Reinsurers
Debt
R0.9bn

-- 24 of 85 --

25
Group is well capitalised and highly liquid
15%
17%
19%
21%
23%
25%
27%
29%
Rm Dec 19
Cover
Dec 20
Cover
1.7x 1.8x
1.7x 1.8x
1.4x 2.0x
1.7x 2.0x
2.2x 1.3x
28%
DHMS solvency
(unaudited)
36.8%
1 Capital Adequacy Ratio
2 Considers SA Liquidity and liquid excess assets for Discovery Life, Discovery Insure, VitalityHealth, VitalityLife and Discovery Bank
3 SA cash + undrawn committed facilities
1
SA Liquidity3 , R millions	FLR R millions
Liquid excess assets above regulatory
capital requirements
Strongly capitalised FLR is within target
Highly liquid across
the Group2
Sufficient liquidity
at the centre
-
200
400
600
800
1,000
1,200
1,400
1,600
1,800
2,000
FY18 FY19 FY20 H121
-
2,000
4,000
6,000
8,000
10,000
12,000
14,000
FY18 FY19 FY20 H121

-- 25 of 85 --

26
Positive non-economic
experience variances
Annualised ROEV, 11.7%
excluding forex and
economic changes
Group Embedded Value
Health
Life
and
Invest
VH VL Total
Lapses* -36 375 67 193 599
Renewal
expenses 102 13 80 25 220
Mortality and
morbidity - 62 92 12 166
Other 261 113 89 -142 321
Total 327 563 328 88 1 306
Opening EV Value of new
business
Unwind of
RDR
Non-economic
experience
variances
Non-economic
methodology
& assumption
changes
Operational
EV
Economic
experience
Forex EV before
below the line
items
Group
initiatives
Other Change in
capital and
dividends
Closing EV
Operational EV Economic impact Initiatives and other
R72 467m
R73 424m
R75 992m
R70 834m
& assumption
changes
*Lapses, surrenders and policy alts

-- 26 of 85 --

A pivot to growth following
trends emerging through
COVID-19
3

-- 27 of 85 --

28
Shared-Value dynamics manifest across all industries
LIFE HEALTH MOTOR
LONG-TERM
SAVINGS
Claims
Lapses
SA UK Market A
Blue Bronze Silver Gold
SA UK
Blue Bronze Silver Gold
SA UK
Blue Bronze Silver Gold
Blue Bronze Silver Gold
BANK
TECHNOLOGY AND
ANALYTICS LAYER
DATA LAYER
BEHAVIORAL LAYER
INCENTIVE LAYER
PRICING LAYER
VITALITY MONEY POINTS VITALITY MONEY STATUS
DEBT
MANAGER	
SPEND	
MANAGER	
ACTIVE	
REWARDS
DEFAULTS
Dynamic interest rates	
Dynamic discounts
MONEY
PRODUCTS
TRANSACTIO	
N	
CREDIT VISA SAVINGS
DYNAMIC	
INTEREST
RATES
DISCO
VERY
MILES	
DYNAMIC	
DISCOUNTS
Spend
Arrears

-- 28 of 85 --

29
The three trends have been accelerated by COVID-19
The rise of digital
Ways of work
Ecommerce
Telemedicine
Contactless
ESG
Moral money
Climate change
Social movements
Mortality
Morbidity
Driving
Investing
Banking
Purpose and
ESG
Focus on wellness
and resilience
Growth of digital
platforms
Importance of
healthcare
Health first
Healthcare ecosystems
Preventative services
Distribution models
Servicing models
Green agenda
Empowered customers

-- 29 of 85 --

30
Importance of physical activity on health and risk
Causal impact of changing
physical activity levels
Impact on hospitalisation Impact on mortality
Adjusted and standardised healthcare
claims by days of qualifying physical
activity
Mortality by disease type by physical
activity
Changing measurements to
more sophisticated health
measures
Extending beyond activity to
Cardio Respiratory Fitness (CRF)
Mortality relativities by CRF levels
[-367,-5) [-5,5) [5,75) [75,366)
Increase
in PA days
per year
Decrease
in PA days
per year
18%
Bayes Network model
18% lower risk of being a high-cost
claimer
1000
1100
1200
1300
1400
1500
0 50 100 150 200 250 300 350
Physical activity days per year
Unknown
CRF
Poor CRF Average
CRF
Good CRF No Vitality Blue Bronze to Diamond
Ischaemic heart disease
Cerebrovascular heart disease
Hypertensive heart disease
Infectious and parasitic diseases
Injuries
Unintentional Injuries
Respiratory diseases
Diabetes mellitus
Digestive diseases
Neurological conditions
Respiratory infections
Unengaged	No Vitality Engaged

-- 30 of 85 --

31
1.0 0.7 0.6
2.6
1.7 1.5
3.0
1.7 1.3
9.0
5.8
4.8
Low Med High Low Med High Low Med High Low Med High
Understanding resilience
Impact of health and lifestyle on COVID-19 related risk COVID-19 mortality by Vitality status
COVID-19 mortality risk by level of physical activity engagement Life COVID-19 mortality
rate by Vitality status
40-49,
no chronic
conditions
40-49,
hypertension
and diabetes
60+
no chronic
conditions
1 Engagement in Vitality can offset the elevated COVID-19 risk
associated with aging
2 Engagement in Vitality can offset the elevated COVID-19 risk
associated with lifestyle chronic conditions
Only clients with at
least one comorbidity
Only clients over
age 60
-71%
Vitality engagement reduces mortality risk regardless of age or
comorbidities
-74%	-81%
60+
hypertension
and diabetes

-- 31 of 85 --

32
Building and curating a wellbeing ecosystem
Institution
C O N S U M E R
ATTRACT UW AND
PRICE
CHANGE
BEHAVIOUR RETAIN
L I N E S O F B U S I N E S S
C O N S U M E R S
Building capability to
translate behaviour to
the different lines of
business
Personal pathways
Access to curated
programmes
Supported by device,
strategic and reward
partners
B E H A V I O U R A L C H A N G E & E N G A G E M E N T
G A T E W A Y
P A R T N E R S
T E C H N O L O G Y A N D A N A L Y T I C S L A Y E R
MEDITATION SLEEP NUTRITION WEIGHT
Calm Headspace Pzizz Sleep cycle MyFitnessPal LoseIt	Lark Shapa Withings	Breathe
Institution
DEVICE STRATEGIC REWARD
Collaborative model assisting customers to manage their health by combining data, incentives, personalisation
and providers
GATEWAY CONNECT GATEWAY GUIDE GATEWAY EXCHANGE

-- 32 of 85 --

33
Discovery Health’s platform

-- 33 of 85 --

34
Comprehensive Digital Health Ecosystem – all in production, fully
integrated into products and the administration/claims platform
INTEGRATED
HEALTH AND
WELLNESS APP
WELLNESS
DEVICE
INTEGRATION
VIRTUAL
CONSULT
PLATFORM
ONSITE
WELLNESS
SERVICES
HOMECARE
SERVICES
CARE CO-
ORDINATED
SERVICES FUNDER
HEALTHID
INTEGRATED ELECTRONIC
HEALTH RECORD AND
INTERACTION PLATFORM
DOCTOR CONNECT
VIRTUAL CONSULT
PLATFORM WITH DEVICE
INTEGRATION
DIAGNOSE
FULL PATIENT
RECORD
INCLUDING
MEDICATION,
PATHOLOGY AND
RADIOLOGY
WELLNESS AND
PREVENTION
PRESCRIBE
PERSONAL DISEASE
MANAGEMENT
PATHWAYS
VITALITY ACTIVE
REWARDS FOR
DOCTORS
CARE AND
TREATMENT
VIRTUAL
CONSULTATIONS
VALUE BASED
CARE PROGRAMS
PRODUCT SUITE
INTEGRATED
CLAIMS AND
ADMINISTRATION
PLATFORM
PATIENT
MANAGEMENT
PLATFORMS
COACHING PLATFORM
DISEASE PREDICTION
MODELS
VALUE BASED
CARE PROGRAMS
MANAGEMENT
CARE PROGRAMS
COACHES AND
CARE MANAGERS
ASSETS
KNOW YOUR
HEALTH
PERSONAL
HEALTH RECORD
HEALTH
INFORMATION
LIBRARY
AI SYMPTOM
CHECKER
SCREENING
WELLNESS AND
PREVENTION
AR2020 +
GATEWAY
VITALITY 65+
NUTRITION
ASSESSMENT AND
COACHING
FITNESS
ASSESSMENT AND
COACHING
CARE AND
TREATMENT
VIRTUAL
CONSULTS WITH
DEVICES
SECOND OPINION
PERSONALISED
DISEASE
MANAGEMENT
MEDICINE
ADHERENCE
CARE
COORDINATION
HOMECARE
SERVICES
ASSETS
ASSETS
PATIENT
DOCTOR

-- 34 of 85 --

35
Growth of digital platforms

-- 35 of 85 --

36
Addressing social issues through the Shared-Value model
INSURED
SOCIETY INSURER
Better health, incentives and a
lower cost of insurance
Fewer deaths
Fewer illnesses
Lower claims
Lower lapses
Healthier society
Improved productivity
Reduced healthcare burden
Make people
healthier
CORE PURPOSE
“It is not a
problem”
“It is a
problem”
“Let’s solve
the
problem”
“It’s an
opportunity“
“Let’s
define
a purpose“
Donations to
worthy social
causes
Volunteering
Mitigating risk
and harm
Improving trust
and reputation
Achieving ESG
standards and
Global Reporting
Initiative
measures
Answering
“why do we
exist?” as a
company
Addressing societal
needs and
challenges through
the business itself,
with a business
model

-- 36 of 85 --

37
Discovery’s climate strategy and impact
Discovery’s emission profile Comparison to JSE Large Cap
A	
B	
C	
D
E	
F	
G
H
I	
J	
K	
L	
M
N
O
P	
Q
R	
S	
T
DSY
JSE Large Cap Companies
Average (26.3m Tons)
SHORT TO MEDIUM TERM
Achieve carbon neutrality in our
SA, UK, and US operations by 2025
(Scope 1 and 2 emissions)
55 548
Tons CO2e per year (2019)
Audited by

-- 37 of 85 --

38
Shared-Valued model conceptually applicable for green behaviour change
controllable
behaviours
of personal
household
emissions
Electricity Nutrition
Driving Flying

-- 38 of 85 --

The businesses well
positioned in the four
strategic strands
4

-- 39 of 85 --

40
The businesses in the four strategic strands
SA COMPOSITE MODEL UK COMPOSITE MODEL PARTNER COMPOSITE
MODEL
Health	
Life	
Invest
Perfect composite model, #1 in every industry, and laboratory for shared value in financial
services. A successful entry into banking
The best insurer in the UK, making use of a composite Shared-Value Model
Vitality is the world’s largest and most sophisticated behavioural platform linked to
financial services, with disciplined execution
Ping An Health delivers on its plan to become the leading health insurer in China with
over 50m clients

-- 40 of 85 --

41
Health	
Life	
Invest
SA COMPOSITE MODEL

-- 41 of 85 --

42
Clients Retail deposits Advances	Accounts
J A S O N D J F M A M J J A S O N D J F J A S O N D J F M A M J J A S O N D J F
2020 2021	2019 2020 2021	2019
J A S O N D J F M A M J J A S O N D J F
2020 2021	2019
300k
S O N D J F M A M J J A S O N D J F
2019 2020 2021
As at 24 February 2021
Post-BIN
migration
Post-BIN
migration
Post-BIN
migration
Post-BIN
migration

-- 42 of 85 --

43
Full suite and differentiated proposition results in diversified
income streams
Savings only
DTA (PAYT)
DTA (Bundled fee)
Credit card
Suite
BIN migrated
New clients and accounts continue to grow steadily with efforts focused
on new-to-Bank clients following the migration
NII NIR 59%
41%
Revenue components
Product mix
New accounts and average daily new-to-Bank
sales
Accounts Average daily sales
>556k
S O N D J F M A M J J A S O N D J
<70
>350
A M J J A S O N D J

-- 43 of 85 --

44
5%
95%
Top 10 deposits as a % of total
Other as a % of total
Retail deposits
Deposits have grown strongly, in line with the strategy to build a retail
deposits-led bank
Deposits are sticky and diverse
By Vitality Money status
Retail deposits tenure
Concentration risk
44%
56%
> 3 months
< 3 months
1% 4% 9% 1%
51%
34%
Blue Bronze Silver Gold Diamond None
International comparison
Discovery Bank deposit growth is best in class
after 14 months of operation
Deposits per customer (R ‘000)
19.8
1.2
7.4 6.3
Discovery
Bank
Tyme Bank Monzo Revolut
J A S O N D J F M A M J J A S O N D J F
2020 2021	2019
97% growth
post-migration

-- 44 of 85 --

45
Advances Credit quality Market share
Advances remained flat reflecting the decrease in consumer spending
and prudent lending approach
0
100
200
300
400
500
600
700
800
Client credit score
Exceptionally low
risk
Low risk
Medium risk
High risk
Very high risk
of clients have their largest credit card
balances with Discovery Bank
0%
10%
20%
30%
40%
50%
60%
1 2 3 4 5+
% of population
DSY balance rank
Discovery Bank balance rank
J A S O N D J F M A M J J A S O N D J F
2020 2021	2019
Post-BIN
migration

-- 45 of 85 --

46
Increasing engagement
VM status agnostic to income levels,
correlations aligned to pricing basis Shared-Value fundamentals
Increasing client engagement and Shared-Value fundamentals emerging
as expected
Jul-20 Aug-20 Sep-20 Oct-20 Nov-20 Dec-20
Base Miles Fuel
HealthyLiving Iphone
Active rewards Miles
Vitality Money take-up Increase in rewards
engagement since Jul-20 lower arrears
rate
higher deposit
levels
greater spend
Blue Bronze Silver Gold Diamond
Vitality Money status
Savings
only
Account type
31% 45% 16% 5% 4%
Gold
43% 33% 15% 5% 3%
Platinum
27% 36% 22% 9% 6%
Black
20% 34% 25% 13% 9%
Purple
10% 25% 24% 14% 27%
Percentage of consumers in arrears
by Vitality Money status
Deposits by Vitality Money status
Spend by Vitality Money status
Three months average
4.4%
0.9% 0.3% 0.2% 0.0%
Blue Bronze Silver Gold Diamond
7,443 8,345 20,200 27,352
131,881
Blue Bronze Silver Gold Diamond
8,093 12,557 19,572 21,147
58,892
Blue Bronze Silver Gold Diamond

-- 46 of 85 --

47
Value drivers are trending in the right direction and the Bank is well-
positioned for growth
Client growth
Deposits
Product mix
Advances
Value drivers Strategic focus areas
Expanding distribution
channels and leads sources
Accelerated issue resolution
Enhanced onboarding
Streamlined credit
application process
Zoom co-browsing
Thought leadership and
brand awareness
Large and highly productive
tied adviser base
Targeting of engaged
Vitality clients
Real-time upselling
Pre-scoring Vitality members
for credit
Numerous features and
propositions in the pipeline

-- 47 of 85 --

48
Operating profit
Rm
Lapses Membership New business*
Rm
to R1 670m lives under administration
5.57%
5.19%
Dec-19 Dec-20
1993	
1995	
1997	
1999	
2001	
2003	
2005	
2007	
2009	
2011	
2013	
2015	
2017	
2019
Non-scheme products
Closed schemes
DHMS
H1
2017
H1
2018
H1
2019
H1
2020
H1
2021
H1
2017
H1
2018
H1
2019
H1
2020
H1
2021
to R3 167m
*New business excl. new closed schemes: -17% to R2 788m
improvement

-- 48 of 85 --

49
Medical scheme growth impacted by the contraction in employment
DHMS growth Closed scheme growth Retail product growth
lives
closed schemes
Jan-18	
Apr-18	
Jul-18
Oct-18	
Jan-19	
Apr-19	
Jul-19
Oct-19	
Jan-20	
Apr-20	
Jul-20
Oct-20
Primary Care Gap cover Healthy Company
1997
1999
2001
2003
2005
2007
2009
2011
2013
2015
2017
2019
lives
LIBERTY
MEDICAL
SCHEME
Type I Type II
H1 2020 H1 2021
DHMS new business API by business type
year-on-year
revenue growth
Net gain of lives in Jan-21
: new employer groups
Type II: new employees on existing groups

-- 49 of 85 --

50
Membership and growth Lapses and stability Security and surplus
1 Council of Medical Schemes
unaudited solvency	credit rating
Plan movements stability
Downgrade
No
movement
Upgrade
lives
market share1 as at Sep 2020
1993
1995
1997
1999
2001
2003
2005
2007
2009
2011
2013
2015
2017
2019
2.2%
1.6%
96.2%
2020 plan movements
Debit order rejections
2002 2004 2006 2008 2010 2012 2014 2016 2018 2020
Increased by
3%
4%
5%
6%
7%
Apr-20
May-20	
Jun-20
Jul-20
Aug-20
Sep-20
Oct-20
Nov-20
Dec-20

-- 50 of 85 --

51
Solvency build-up driven by the decline in non-COVID-19 healthcare
utilisation
2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Surplus build-up
emerging due to
COVID-19
R27.5bn
R19.2bn
Impact on utilisation
Weekday OH claims index
(rolling 3-day average)
Weekday hospital admissions index
(rolling 3-day average) Private
hospitals Day clinics	Psychiatric
hospitals
Radiologists Paediatricians	GPs
Claim cost change by service month
Claim cost change by service month
14.6%
-79.6%
4.2%
38.7%
6.9%
Jan…
Mar
May
Jul
Sep
Nov
Jan…
22.7%
-48.0%
-30.5%
-6.5%	
Jan…
Mar
May
Jul
Sep
Nov
Jan…
8.9%
-44.9%
-10.1%
3.0%
Jan…
Mar
May
Jul
Sep
Nov
Jan…
2020	
2021	
2020	
2021	
2020	
2021
3.4%
-10.2%
-39.5%
-32.2%
3.7%
-13.1%
Jan…
Mar
May
Jul
Sep
Nov
Jan…
7.9%
-40.2%
-21.8%
-30.8%
-19.3%
1.9%
Jan…
Mar
May
Jul
Sep
Nov
Jan…
8.1%
-49.0%
-30.9%
8.2%
-22.6%
Jan…
Mar
May
Jul
Sep
Nov
Jan…
2020	
2021	
2020	
2021	
2020	
2021
DHMS solvency results projected with IBNR, unaudited

-- 51 of 85 --

52
New business Normalised operating profit
to R1 162m to R1 922m
Exceptionally strong operating
variances
Positive non-economic variances
Includes Discovery Invest
H1 2017 H1 2018 H1 2019 H1 2020 H1 2021	H1 2017 H1 2018 H1 2019 H1 2020 H1 2021
Impact of c.R1.8bn capital release at June 20
Impact of c.R166m in Group Life claims not
covered by COVID-19 provision
224
Lapses and surrenders
Policy alterations
Mortality and morbidity	
Premium and fee income
Other	
Total
H1 2020 H1 2021 563
Lapses and surrenders
Policy alterations
Mortality and morbidity	
Premium and fee income
Other	
Total

-- 52 of 85 --

53
Positive operational experience variances, driven by exceptionally strong
persistency
81.0%
90.2%
Count EV
H1 2020 H1 2021
Resilient value of new business and increase in embedded value	Strong lapse experience and improvement in
non COVID-19 claims experience
100%
Lapse experience AvE
105.9%
99.6%
H1 2020 H1 2021
EV variance
Claims experience AvE
(excl identified COVID-19 claims)
408
291
H1 2020 H1 2021
9.5%
5.9%
8.2%
H1 2020 FY 2020 H1 2021
VNB (Rm) Life: Annualised VNB margin (%)
Life:
Jun-20 Dec-20
Embedded value: Life and
Invest
R31.8bn
R33.8bn
Driven by:
• Tight expense controls
• Improved business mix
• Economic assumption changes
Margin improved vs. June 20

-- 53 of 85 --

54
Dec-19 Jun-20 Dec-20 Adjusted for
claims up to
mid-February
Robust position evident in strong cashflow, capital coverage and liquidity
Strong cash emergence over the
period
Life and Invest
R millions
Maintained strong capital position High levels of liquidity coverage
182%	182%
172%
Dec-20	Jun-20	Dec-19
125%
SCR
target
R4.1bn Assets available to
meet liquidity
needs
R2.8bn
R4.1bn
Premiums and Fees
Net Claims
Operational costs
Cashflows from existing
NB Strain
Cashflow before FinRe
Net FinRe
Life&Invest Net cashflow
7 605
2 050
653 231
cR560m of COVID-19
claims paid within the
period, largely offset by
FinRe recovery
NB and servicing strain

-- 54 of 85 --

55
COVID-19 claims experience peaked in January 2021, and has run down
materially as at mid-February
Significant provision utilisation during
the January peak, has abated during
February
Total provisions in excess R1bn remain even
after allowing for Jan and Feb claims
Amplified relevance of shared-value
life insurance through the pandemic
31-Dec-20
7-Jan-21
14-Jan-21	
21-Jan-21	
28-Jan-21	
4-Feb-21
11-Feb
18-Feb
Weekly progression
Increase in claims
provision utilisation
over 4 weeks
Total Claims Paid
R393m
R987m
R418m
R532m
R652m
R807m
R1 044mR1 070m
594
83
31-Dec-20 January Claims 1st-18th
February claims
Total Provision at
mid-February
R1 741m
R1 064m
Feb-19
Jun-19
Oct-19
Feb-20
Jun-20
Oct-20
Lowest since inception
Lapse rate
Death claims
(actual vs expected)
Counter to higher
claims through this
period has been
significantly lower
lapse experience
31-Mar	
14-Apr	
28-Apr	
12-May	
26-May
9-Jun
23-Jun
7-Jul
21-Jul
4-Aug
18-Aug
1-Sep
15-Sep	
29-Sep	
13-Oct	
27-Oct	
10-Nov	
24-Nov
8-Dec
22-Dec
5-Jan
19-Jan	
2-Feb
16-Feb
Exposed Life benefits (R'm)
on 127 lives
on 386 lives
Death claims in the 1st and 2nd waves
Feb-19
Jun-19
Oct-19
Feb-20
Jun-20
Oct-20
Highest since inception
Clients have
recognised the
value of keeping
their cover in place

-- 55 of 85 --

56
H1 2017 H1 2018 H1 2019 H1 2020 H1 2021
to R1 316m
New business
Rm
Assets under administration	Normalised operating profit
Rm
20
16
20
17
20
18
20
19
20
20
to R107bn
2016 2017 2018 2019 2020	H1 2017 H1 2018 H1 2019 H1 2020 H1 2021
to R471m
Rbn

-- 56 of 85 --

57
Efficacy of Shared-Value model works locally and is moving abroad
Discovery Invest platform
Shared-Value model produces
exemplary outcomes
Discovery Internal data 31 December 2020. Flows data from ASISA as at 31 December 2020.
Performance data as per Morningstar 31 December 2020
Actual
v expected
Proposition has created the fastest
growing retail investment provider
Dec-07	
Sep-08	
Jun-09	
Mar-10	
Dec-10	
Sep-11	
Jun-12	
Mar-13	
Dec-13	
Sep-14	
Jun-15	
Mar-16	
Dec-16	
Sep-17	
Jun-18	
Mar-19	
Dec-19	
Sep-20
Asset growth (rebased to 100 as at 31 Dec 2007)
AUM Growth since December
2007
Discovery Competitor A Competitor B
Competitor C Competitor D Competitor E
Competitor F Competitor G Competitor H
Competitor I Competitor J Competitor K
Competitor L Competitor M
Actuarial dynamics
Vote of confidence during COVID
Withdrawals Paid-ups
Digital technology and quality servicing
Data
Incentives
Behaviour
invested in
preferred funds
lower
lapse rates
more ad-hoc
contributions
lower
drawdowns
Actual
v expected

-- 57 of 85 --

58
to 6%*	to R107m
(excl. Commercial)
to R2 121m*
H1
2017
H1
2018
H1
2019
H1
2020
H1
2021
H1
2017
H1
2018
H1
2019
H1
2020
H1
2021
to R617m*
H1
2017
H1
2018
H1
2019
H1
2020
H1
2021
H1
2017
H1
2018
H1
2019
H1
2020
H1
2021
New business Market share in GWP Operating margin
Gross written
premium
H1
2017
H1
2018
H1
2019
H1
2020
H1
2021
*Personal Lines only. Assumes 6% in GWP
market growth since 2018	*Personal Lines only
Normalised
operating profit

-- 58 of 85 --

59
16%
8%
5% 4%
2%
-7%
Increased margin a direct result of the economics of the model
Year 1 Year 2 Year 3 Year
4+	
Gold	
Blue
Bronze
Silver
Year 1 Year 2 Year 3 Year
4+
Public buy-in
Source: NAAMSA; Property24
2020 Growth in GWP
-3
-1
3
4
6
H1
2017
H1
2018
H1
2019
H1
2020
H1
2021
Margin (%)
Shared-Value model drives the economics Resultant margin
Lapse rates
Gold	
Blue
Bronze
Silver
Loss ratios
By Vitality status By duration inforce
Lapse rates	Loss ratios
Despite a
decline in home
transfers and new
vehicle sales in 2020,
DSY Insure new
business sales stayed
strong at

-- 59 of 85 --

60
Data provides fascinating advantage in insights and application
Blue Bronze Silver Gold
Volkswagen
Toyota
Ford
Mercedes-Benz
BMW
Hyundai
Audi
Blue Bronze Silver Gold
Female
Male
Blue Bronze Silver Gold
18-30
31-50
51-65
65+
Blue Bronze Silver Gold
Gauteng
Western Cape
Kwazulu-Natal
Eastern Cape
Other
Vitality drive status differentiates risk within traditional pricing factors
Frequency of claims by Vitality Drive Status
Age Province Gender Automobile
Actual DSY Experience
Discovery Pricing
Non-Telematics Pricing
Blue Bronze Silver Gold
Competitors underpricing
and making losses
Competitors overpricing; DSY
rewarding clients for better risks
Understanding behaviour
provides superior accuracy over
traditional pricing

-- 60 of 85 --

61
Model and data enables emphasis on the customer and is replicable
Vitality Drive 2.0
Vitality Drive 65+	Discovery Insure
vehicle warranty
kilometres tracked
claims paid
cashback paid
Discovery Insure’s personal lines platform Platform enables capabilities and new manifestations
insured assets
International expansion
claims processed
rewards earned

-- 61 of 85 --

62
Health	
Life	
Invest
UK COMPOSITE MODEL

-- 62 of 85 --

63
New business	Earned premiums	Normalised operating profit Lives covered
to 1.3m lives
GBP millions
to £409.4m* to £56.4m
GBP millions
H1
2017
H1
2018
H1
2019
H1
2020
H1
2021
H1
2017
H1
2018
H1
2019
H1
2020
H1
2021
to £44.2m
GBP millions
H1
2017
H1
2018
H1
2019
H1
2020
H1
2021
H1
2017
H1
2018
H1
2019
H1
2020
H1
2021
Health and Life
insurance
*Excludes UPR adjustment
Excludes Vitality at Work (formerly Healthy
Workplace and Essentials)

-- 63 of 85 --

64
Service recognition
The composite is working well and receiving recognition
Vitality engagement:
deep and correlated
UKCXA’20
UK Customer Experience Awards
Celebrating women in sport
Brand well established
Simplified customer
journeys
Neoplasms
Musculoskeletal
Cardiovascular
Respiratory
Bronze Silver Gold Platinum
Relative IH claims experience
Relative lapse experience
Source:
Mortality: Vitality impact on mortality (using causal inference), 2016-2020
Morbidity: Vitality Continuous Mortality, Lapse and Engagement (CMLE) investigation, 2017. Standardised for Age, Gender, SE Class, Initial RUB; Rebased to Bronze status
Retention: 12-mth Rolling Average Actual VS Expected Lapse Rates for Optimised policies by Vitality Status
Leading companies evaluated:
Overall Winner
Workplace
Wellbeing Team
Relative mortality rates
Bronze
unengaged
Bronze
engaged
Silver Gold Platinum
14
19
25 29 30
37
50 50 51 53
H2
2014
H1
2017
H1
2019
H1
2020
H2
2015
No
measure
H2
2020
COVID-19
Prompted brand awareness

-- 64 of 85 --

65
Shared-Value Insurance Model is consistent across the Group
LIFE
OPTIMISER
ABC RENEWAL
PRICING
HEALTHY FEE
SAVER
STATUS-LINKED
EXCESS
Healthier ageing and
improved financial
wellbeing
Improved driving, both
safer and greener
Improved morbidity
and mortality
Improved
morbidity
Up to 0% asset
management fees
Reduce excess by up
to £250 and
eliminate increase
Up to 30% upfront
discount
Reduce increase
through health
engagement

-- 65 of 85 --

66
New business	Lives covered	Normalised operating profit
to 693k lives*
Earned premiums
GBP millions
to £256.5m* to £30.0m
GBP millions
H1
2017
H1
2018
H1
2019
H1
2020
H1
2021
to £28.8m
GBP millions
H1
2017
H1
2018
H1
2019
H1
2020
H1
2021
H1
2017
H1
2018
H1
2019
H1
2020
H1
2021
H1
2017
H1
2018
H1
2019
H1
2020
H1
2021
Health insurance
*Excludes UPR adjustment *Excludes Vitality at Work (formerly Healthy
Workplace and Essentials)

-- 66 of 85 --

67
The quality of the book is strong
H1 2017 H1 2018 H1 2019 H1 2020 H1 2021
Exceptional retention
Lapse rates
Strong cash generation after allowing for UPR adjustment
GBP millions, after allowing for COVID-19 provisions
0
10
20
30
40
50
60
70
H1 2018 H1 2019 H1 2020 H1 2021
0
10
20
30
H1 2018 H1 2019 H1 2020 H1 2021
Inforce book cash generation Net cash generated
£46m £47m £51m
£59m
£22m £20m £23m £25m

-- 67 of 85 --

68
UPR adjusted for treatments delayed due to COVID-19, and roughly
equal to 2 months of claims
0%
20%
40%
60%
80%
100%
120%
Cardiac Musculoskeletal Oncology Psychiatry Overall
Monthly authorisations per 1 000 lives
Pre COVID-19
Still below expectation due to second wave, but expect
catch-up on delayed treatments	Authorisations still below pre-COVID-19 levels
Claims spend expected compared to authorisations received
0%
20%
40%
60%
80%
100%
120%
140%
Jan-20	
Feb-20	
Mar-20	
Apr-20	
May-20	
Jun-20	
Jul-20
Aug-20	
Sep-20	
Oct-20	
Nov-20	
Dec-20	
Jan-21	
Feb-21	
Mar-21	
Apr-21	
May-21	
Jun-21
%age of normal claims spend expected in business plan
UPR provision roughly 2 months of claims
Wave 1 Wave 2

-- 68 of 85 --

69
to 648k lives
New business	Lives covered	Normalised operating profit Earned premiums
to £152.9m
GBP millions
to £26.4m
GBP millions
H1
2017
H1
2018
H1
2019
H1
2020
H1
2021
to £15.4m
GBP millions
H1
2017
H1
2018
H1
2019
H1
2020
H1
2021
H1
2017
H1
2018
H1
2019
H1
2020
H1
2021
H1
2017
H1
2018
H1
2019
H1
2020
H1
2021
Life insurance

-- 69 of 85 --

70
COVID-19 impacted the overall market with a reduction in total sales
Q1 2019 Q2 2019 Q3 2019 Q4 2019 Q1 2020 Q2 2020 Q3 2020
-22% -23%
Source: Touchstone, Oct 2020
COVID-19 impact
to £26.4m
GBP millions
H1 2017 H1 2018 H1 2019 H1 2020 H1 2021
VitalityLife new business UK IFA market new business

-- 70 of 85 --

71
Vitality Life benefitting from the restructure
0%
20%
40%
60%
80%
100%
120%
H1
2016
H1
2017
H1
2018
H1
2019
H1
2020
H1
2021
Steps taken to address retention
Unfavourable variances remedied
from July 2020	Lapse AvE at all-time low
AvE lapses
Expected
IFRS reserve variance
-4
-3
-2
-1
0
1
2
3
Jul-19	
Aug-19	
Sep-19	
Oct-19	
Nov-19	
Dec-19	
Jan-20	
Feb-20	
Mar-20	
Apr-20	
May-20	
Jun-20	
Jul-20	
Aug-20	
Sep-20	
Oct-20	
Nov-20	
Dec-20
Millions

-- 71 of 85 --

72
H1 20 before
experience
variances
H1 20 actual
before interest
and hedge
impact
Interest and
hedge impact
H1 20 operating
loss
H1 20 restated
operating profit
Profits are reverting, as expected
£9m
-£7m
£15m Reduction due
to experience
variances
-£16m
H1 2020 normalised operating profit recon H1 2021 operating profit recon
H1 21 expected Experience
variances
Strengthening
of provisions
Interest and
hedge impact
H1 2021
operating profit
£15.4m
£15m
£7.6m
Lapses
+£9.4m -£8.9m
£5.8m

-- 72 of 85 --

73
Health	
Life	
Invest
PARTNER COMPOSITE
MODEL

-- 73 of 85 --

74
New business1 Written premium1
PAH’s operating results
pre-tax
Discovery’s operating
result after tax
to R7.2bn to R18.1bn to R1bn
(DSY’s share is R253m)
to R112m
1 100% of PAH
H1
2017
H1
2018
H1
2019
H1
2020
H1
2021
H1
2017
H1
2018
H1
2019
H1
2020
H1
2021
H1
2017
H1
2018
H1
2019
H1
2020
H1
2021
H1
2017
H1
2018
H1
2019
H1
2020
H1
2021

-- 74 of 85 --

75
-
1
2
3
4
5
6
7
8
2017 2018 2019 2020
Billions
Exceptional new business growth in the 1st half of PAH’s financial year
Six-monthly new business
RMB
Although new business slowed in the latter half, it
achieved its full-year revenue target
2020	2019	2018	2017
0
1
2
3
4
5
Jan-Jun Jul-Dec Jan-Jun Jul-Dec Jan-Jun Jul-Dec Jan-Jun Jul-Dec
Billions
+26%
Calendar year new business RMB
+35%
+105%

-- 75 of 85 --

76
PAH continues to focus on growth and broadening its sales channels
Continued expansion of offline
distribution footprint
Transformed distribution strategy to
capture different parts of market
Agents
Business
Customer
Government
2A
2B
2C
2G
Deepen collaboration with
Ping An Group subsidiaries
Partner with major third-
party platforms
SuiShenYi platform
Group business through
large established brokers &
PAH’s own direct sales team
Micro top-up medical
reimbursements products
Building digital distribution
strategy for agents
Commission
My Sales Status
My Sales tracker
Pending
payment Completed Expired
3 days ago
SuiShenYi
platform
Online platform where
anyone can register to
be an agent to sell PAH
insurance products
Henan Jiangsu
Shanghai
Zhejiang
Guangdong
Hubei
Chongqing
Sichuan
Beijing Liaoning
Tianjin
Shenzhen
Tier 2 branches:
Beijing, Shanghai, Guangdong, Shenzhen, Jiangsu,
Zhejiang, Liaoning, Tianjin, Sichuan, Suzhou, Hebei,
Chongqing, Henan, Hubei
Hubei added Nov 2020

-- 76 of 85 --

77
Ping An Group continues to invest in its extensive healthcare ecosystem
Government
Patients Provider
Technology
Payer
PA Good Doctor
903K daily
consultations
Online
Offline
PA Good Doctor
Health
commissions
Ping An Life
Ping An Annuity
HealthKonnect
Ping An Health
Research Institution Investment Institution
Healthcare Technology
Research Institute
Toda
Bio-research Voyager
Global Fund
Ping An
Ventures
Overseas
Holdings
PAH benefits from this
Group investment
through products,
networks and channels
The ecosystem brings
together users with
online and offline
providers of products
and services
The ecosystem is
served by a single
digital platform
Medical products
administration
Healthcare security
administration
Implemented in 158 cities
across 30 provinces
Ranked 1st globally by digital healthcare
applications
Invested in nearly 100 companies in the
healthcare industry
373m registered users
PA Good Doctor PA Good Doctor
21K institutions
Institutions Doctors Pharmacies
1000+ partner
hospitals across
world
650K doctors
served
21K+ external
contracted
doctors
150K+ partner
pharmacies
Digital platform strategy with integration of various offline players

-- 77 of 85 --

78
PAH app being merged into Good Doctor app, which is to become the
digital platform serving the Ping An Group healthcare ecosystem
Mission: provide full range of health management
services covering prevention, treatment and
rehabilitation
Important flagship of Ping An’s healthcare ecosystem
bringing users into an ecosystem of product and
service providers
New app is called
Ping An Health
Vision: bring health to all
Chinese and promote the
construction of Healthy China,
promoting the transition from
disease treatment-centric to
health-centric
Ping An Good Doctor: China’s leading online
healthcare services platform
Registered users Average daily
consultations
Monthly active users in millions as at Sep 2020
67
5
Ping An
Good Dr
We-
Doctor
Ali
Health
JD
Health
Jianke ChunYu
YiSheng
Hao Dr DXY Zhi
Yuan
Wei
Mai

-- 78 of 85 --

79
Health	
Life	
Invest
PARTNER COMPOSITE
MODEL

-- 79 of 85 --

80
H1
2017
H1
2018
H1
2019
H1
2020
H1
2021
Integrated new API by
insurance partners Revenue Operating result
Insurance and franchise
partners membership
All numbers exclude new VG initiatives, i.e. myOwn and Vitality1
*From insurance partners
H1
2017
H1
2018
H1
2019
H1
2020
H1
2021
Vitality USA Insurance Partners
H1
2017
H1
2018
H1
2019
H1
2020
H1
2021
R8.7bn R625m
2.1m
H1
2017
H1
2018
H1
2019
H1
2020
H1
2021
USD537m USD38m USD14.6m
R238m
(+116% ZAR)	(+21% ZAR)	(+0.3% ZAR)

-- 80 of 85 --

81
Integrated new API by
insurance partners
All numbers exclude new VG initiatives, i.e. myOwn and Vitality1
*From insurance partners
H1
2017
H1
2018
H1
2019
H1
2020
H1
2021
R8.7bn
USD537m
(+0.3% ZAR)
In-market growth continued, despite challenging environment
*AIA and Sumitomo figures are for 2020 calendar year. John Hancock and Generali relative figures are over FY2021H1.
Vitality’s health and wellness message resonated with buyers and helped our partners
build resilient businesses during COVID-19
Vitality integrated	Non-integrated
J A P A N	U S A	A L L M A R K E T S
Sales growth 2020 v 2019	
(pp difference rebased to non
-integrated)
G E R M A N Y
Member growth	
Relative to 2020H1

-- 81 of 85 --

82
Vitality engagement remained strong across our markets
0%
25%
50%
75%
100%
125%
150%
175%
1-Sep-19 1-Dec-19 1-Mar-20 1-Jun-20 1-Sep-20 1-Dec-20
Relative engagement
COVID
Resilient Vitality engagement
during COVID-19
Markets experienced a moderate decline in Q1 with global
uncertainty and lockdowns taking effect
2020 Q3 and Q4 showed the effect of various market
interventions implemented and easing of lock-down measures
Vitality enabled partners to respond and drive
engagement with clients during COVID-19
2019 2020 2019 2020
Total workouts At home workouts
Avg per person
2020Q2 2020Q3
Physically active Engaged v Unengaged
% of members
Jan-20
Feb-20
Mar-20
Apr-20
May-20
Jun-20
Jul-20
Aug-20
Sep-20
Oct-20
Nov-20
Dec-20
Goal completion
Equivida Saludsa
Active Rewards goal
achievement rate
Ecuador’s largest virtual gym
Vitality Run&Walk Challenge
Mobilised a powerful COVID-19
response, with Vitality at its core
COVID-19 DATA ANALYSIS
INCENTIVES FOR VACCINATION
PROMOTIONS AND GUIDANCE
SOCIAL
STRATEGY PLAYBOOK
COMMUNICATION TOOLS
SUPPORT

-- 82 of 85 --

83
Vitality localised and tailored to market needs
Vitality spans multiple markets, regulators, languages, time zones, vendors, rewards partners, currencies and types of financial services
Prudential
Argentina
ASR
Netherlands
IGI Life
Pakistan
Fidelidade
Portugal
SaludSA
Ecuador
Tawuniya
Saudi Arabia
National champions
John Hancock
USA
Manulife
Canada
Generali
Germany
AIA
South Korea
AIA
Singapore
AIA
Australia
AIA
Indonesia
AIA
Philippines
AIA
Hong Kong
AIA
Thailand
Franchise markets
VG
USA
Employee wellness
Aetna Attain
USA
Powered by
Generali
Austria
Generali
France
Manulife is a trademark of The Manufacturers Life Insurance Company and are used by it, and by The Discovery Group under license

-- 83 of 85 --

84
+8% including DH take-on of new closed
schemes and gross revenue for Vitality Group
Core new business API
to R9 916m
Normalised operating
profit
to R4 507m
Normalised headline
earnings
to R2 284m
COVID-19 provisions Headline earnings
to R1 842m	unchanged
SA COMPOSITE MODEL UK COMPOSITE MODEL PARTNER
COMPOSITE MODEL
Health	
Life	
Invest
Robust operating performance with prudent COVID-19 provision
Operating model performing well and driving growth, with strength in capital and liquidity
A pivot to growth following trends emerging through COVID-19
The businesses well positioned in the four strategic strands

-- 84 of 85 --

85
85
for the six months ended 31 December 2020

-- 85 of 85 --